Introductory Clinical Pharmacology Test Bank for Roa
g g g g g g
ch's By Ford MN RN CNE, Susan M TEST BANK
g g g g g g g g g
With Rationale
g
1. Agnursingginstructorgisgpreparinggagteachinggplangforgaggroupgofgnursinggstudentsgabout
gpharmacology.gWhengdescribinggthisgtopic,gtheginstructorgwouldgfocusgthegdiscussiong
ongwhichgofgthegfollowinggasgangessentialgaspect?
A) Druggname
B) Druggclass
C) Druggaction
D) Druggsource
gAns:g CgFeedbac
k:
Pharmacologygisgthegstudygofgdrugsgandgtheirgactiongonglivinggorganisms.gThus,gangesse
ntialgaspectgofgpharmacologygisgdruggaction.gAngunderstandinggofgthegdruggname,gdruggc
lass,gandgdruggsourcegisgimportant,gbutgthegmostgcriticalgaspectgrelatedgtogpharmacology
gisghowgthegdruggactsgingthegbody.
2. Agnursinggstudentgisgpreparinggtogadministergagprescribedgdruggtogagpatient.gThegstudent
greviewsginformationgaboutgthegdruggandgitsgactions.gWhichgofgthegfollowinggwouldgbegt
hegbestgchoicegforgobtaininggthisginformation?gSelectgallgthatgapply.
A) Nursingginstructor
B) Nursegassignedgtogthegpatient
C) Clinicalgdruggreference
D) Prescribingghealthgcaregprovider
E) Clinicalgpharmacist
gAns:gC,gE
Feedback:
Althoughgthegnursinggstudentgcangaskgthegnursingginstructor,gthegnursegassignedgtogthegp
atient,gandgthegprescribingghealthgcaregprovidergforginformationgaboutgthegdrug,gthegbestg
choicesgforgdrugginformationgwouldgincludegangappropriategdruggreferencegandgthegclini
calgpharmacist.
3. Whengdescribinggthegvariousgtypesgofgmedicationsgtogaggroupgofgnursinggstudents,g
agnursingginstructorgwouldgidentifygwhichgofgthegfollowinggasgagsourcegforgderivin
ggmedications?gSelectgallgthatgapply.
A) Plants
B) Syntheticgsources
C) Mold
D) Minerals
E) AnimalsgAn
s:gA,gB,gC,gD,gE
Feedback:
Medicationsgaregderivedgfromgnaturalgsources,gforgexample,gplants,gmolds,gminerals,gan
dganimals,gasgwellgasgcreatedgsyntheticallygingaglaboratory.
Pageg 1
,Introductory Clinical Pharmacology Test Bank for R
g g g g g g
oach's By Ford MN RN CNE, Susan M TEST BANK
g g g g g g g g g
With Rationale
g
4. Whichgofgthegfollowinggnamesgmaygbegassignedgtogagdruggduringgthegprocessg
ofgdevelopment?gSelectgallgthatgapply.
A) Chemicalgname
B) Officialgname
C) Pharmacologicgname
D) Tradegname
E) Nonproprietarygname
gAns:g A,gB,gD,gE
Feedback:
Throughoutgthegprocessgofgdevelopment,gdrugsgmayghavegseveralgnamesgassignedgtogth
emgincludinggagchemicalgname,gaggenericg(nonproprietary)gname,gangofficialgname,gandg
agtradegorgbrandgname.
5. Agdruggmaygbegclassifiedgbygwhichgofgthegfollowing?gSelectgallgthatgapply.
A) Thegchemicalgtypegofgthegdrug'sgactivegingredient
B) Thegwaygthegdruggisgusedgtogtreatgagspecificgcondition
C) Theggenericgnamegofgthegdrug
D) Thegtradegnamegofgthegdrug
E) Thegnonproprietarygnamegofgthegdru
ggAns:gA,gB
Feedback:
Agdruggmaygbegclassifiedgbygthegchemicalgtypegofgthegactivegingredientgorgbygthegwaygitg
isgusedgtogtreatgagparticulargcondition.gGeneric,gtrade,gandgnonproprietarygrefergtoghowga
gdruggisgnamed.
6. Aggroupgofgnursinggstudentsgaregreviewingginformationgaboutgthegprocessgofgdruggde
velopmentgingthegUnitedgStates.gThegstudentsgdemonstrategunderstandinggofgthisgpro
cessgwhengtheygidentifygthatgwhichgofgthegfollowinggcategoriesgaregassignedgbygthegF
oodgandgDruggAdministrationgtognewlygapprovedgdrugs?gSelectgallgthatgapply.
A) Metabolite
B) Noncontrolledgsubstance
C) Prescription
D) Nonprescription
E) Controlledgsubstance
gAns:gC,gD,gE
Feedback:
Oncegdrugsgaregapprovedgforguse,gthegFDAgassignsgthegdruggtogonegofgthegfollowinggcat
egories:gprescription,gnonprescription,gorgcontrolledgsubstance.gMetabolitegrefersgtogtheg
inactivegformgofgthegdrug.gNoncontrolledgsubstancegisgagtermgthatgisgnotgused.
Pageg 2
,Introductory Clinical Pharmacology Test Bank for R
g g g g g g
oach's By Ford MN RN CNE, Susan M TEST BANK
g g g g g g g g g
With Rationale
g
7. hichgofgthegfollowinggwouldgbegmostgimportantgforgthegnursegtogdogtogensuregthegsaf
egusegofgprescriptiongdrugsgingtheginstitutionalgsetting?gSelectgallgthatgapply.
A) Administeringgdrugs
B) Monitoringgclientsgforgdruggeffects
C) Prescribinggdrugs
D) Evaluatinggclientsgforgtoxicgeffects
E) Educatinggclients/caregiversgaboutgdrugs
gAns:gA,gB,gD,gE
Feedback:
Ingtheginstitutionalgsetting,gthegnurse'sgrolegtogensuregsafegusegofgprescriptiongdrugsgincl
udesgadministeringgdrugs,gmonitoringgdruggeffects,gevaluatinggforgtoxicgeffects,gandgedu
catinggclientsgandgcaregiversgaboutgdrugs.
8. Thegnursegisghelpinggagclientgreviewgagprescriptiongfromgtheghealthgcaregprovider.gWhe
ngexamininggthegprescription,gwhichgofgthegfollowinggwouldgthegnursegexpectgtogfindg
documented?gSelectgallgthatgapply.
A) Namegofgthegdrug
B) Dosagegofgthegdrug
C) Routegofgdruggadministration
D) Timesgofgdruggadministration
E) Licensedgprescriber'sgsignatur
egAns:gA,gB,gC,gD,gE
Feedback:
Thegprescriptiongmustgcontaingthegclient'sgname,gthegnamegofgthegdrug,gthegdosage,gtheg
methodgandgtimesgofgadministration,gandgthegsignaturegofgtheglicensedghealthgcaregprovi
dergprescribinggthegdrug.
9. Aftergteachinggaggroupgofgnursinggstudentsgaboutgnonprescriptiongdrugs,gthegnursinggin
structorgdeterminesgthatgthegteachinggwasgsuccessfulgwhengthegstudentsgidentifygwhichg
ofgthegfollowing?gSelectgallgthatgapply.
A) Theygrequiregaglicensedghealthgcaregprovider'sgsignature.
B) Theygaregreferredgtogasgover-the-countergdrugs.
C) Theygcangbegtakengwithoutgriskgtogthegclient.
D) Theyghavegcertainglabelinggrequirements.
E) Theygshouldgbegtakengonlygasgdirectedgongtheglabel
.gAns:gB,gD,gE
Feedback:
Nonprescriptiongdrugsgaregoftengreferredgtogasgover-the-
counterg(OTC)gdrugs.gTheygdognotgrequiregagprescriptiong(aglicensedghealthgcaregprovid
er'sgsignature)gbutgdognotgcomegwithoutgriskgtogthegclient.gThegfederalggovernmentghasgi
mposedglabelinggrequirementsgofgOTCgdrugsgandgtheygshouldgonlygbegtakengasgdirected
gongtheglabelgunlessgundergthegsupervisiongofgaghealthgcaregprovider.
Pageg 3
, Introductory Clinical Pharmacology Test Bank for R
g g g g g g
oach's By Ford MN RN CNE, Susan M TEST BANK
g g g g g g g g g
With Rationale
g
10. AgnursinggstudentgisgreviewingginformationgaboutgthegControlledgSubstancesgActgofg
1970.gThegstudentgwouldgexpectgtogfindgwhichgofgthegfollowinggasgbeinggregulatedgf
orgdrugsgclassifiedgasgcontrolledgsubstances?gSelectgallgthatgapply.
A) Manufacturing
B) Elimination
C) Distribution
D) Formulation
E) Dispensing
gAns:gA,gC,gE
Feedback:
ThegControlledgSubstancesgActgofg1970gregulatesgthegmanufacture,gdistribution,gandgdis
pensinggofgdrugsgclassifiedgasgcontrolledgsubstances.gEliminationgrefersgtogthegexcretion
gofgdrugsgfromgthegbody,gagpharmacokineticgactivity.gThegactgdoesgnotgaddressgformulati
ongofgthegdrug.
11. WhengreviewingginformationgaboutgthegOrphangDruggProgram,gwhichgofgthegfollowin
ggwouldgthegnursegexpectgtogfind?gSelectgallgthatgapply.
A) Thegprogramgencouragesgthegdevelopmentgandgmarketinggofgproductsgtogtreatgrar
egdiseases.
B) Thegprogramggrantsgprovisionalgapprovalgwithgagwrittengcommitmentgfromgth
egdruggcompanygtogformallygdemonstrategclientgbenefits.
C) Thegprogramgprovidesgforgincentives,gsuchgasgresearchggrants,gprotocolgassistance
,gandgspecialgtaxgcredits,gtogdevelopgproductsgtogtreatgraregdiseases.
D) Thegprogramggrantsg7gyearsgofgexclusivegmarketinggrightsgtogthegmanufacturergi
fgapproved.
E) Thegprogramgacceleratesgapprovalgofgdrugsgbasedgongpreliminarygevidencegbefor
egformalgdemonstrationgofgclientgbenefits.
Ans:g A,gC,gD
Feedback:
ThegOrphangDruggProgramgencouragesgthegdevelopmentgandgmarketinggofgproductsguse
dgtogtreatgraregdiseases.gThegprogramgprovidesgincentivesgtogencouragegmanufacturersgt
ogdevelopgorphangdrugs,gandgifgapproved,gthegmanufacturerghasg7gyearsgofgexclusivegm
arketinggrights.gAcceleratedgprogramsginvolvegprovisionalgapprovalgandgapprovalgbased
gongpreliminarygevidence.
Pageg 4
g g g g g g
ch's By Ford MN RN CNE, Susan M TEST BANK
g g g g g g g g g
With Rationale
g
1. Agnursingginstructorgisgpreparinggagteachinggplangforgaggroupgofgnursinggstudentsgabout
gpharmacology.gWhengdescribinggthisgtopic,gtheginstructorgwouldgfocusgthegdiscussiong
ongwhichgofgthegfollowinggasgangessentialgaspect?
A) Druggname
B) Druggclass
C) Druggaction
D) Druggsource
gAns:g CgFeedbac
k:
Pharmacologygisgthegstudygofgdrugsgandgtheirgactiongonglivinggorganisms.gThus,gangesse
ntialgaspectgofgpharmacologygisgdruggaction.gAngunderstandinggofgthegdruggname,gdruggc
lass,gandgdruggsourcegisgimportant,gbutgthegmostgcriticalgaspectgrelatedgtogpharmacology
gisghowgthegdruggactsgingthegbody.
2. Agnursinggstudentgisgpreparinggtogadministergagprescribedgdruggtogagpatient.gThegstudent
greviewsginformationgaboutgthegdruggandgitsgactions.gWhichgofgthegfollowinggwouldgbegt
hegbestgchoicegforgobtaininggthisginformation?gSelectgallgthatgapply.
A) Nursingginstructor
B) Nursegassignedgtogthegpatient
C) Clinicalgdruggreference
D) Prescribingghealthgcaregprovider
E) Clinicalgpharmacist
gAns:gC,gE
Feedback:
Althoughgthegnursinggstudentgcangaskgthegnursingginstructor,gthegnursegassignedgtogthegp
atient,gandgthegprescribingghealthgcaregprovidergforginformationgaboutgthegdrug,gthegbestg
choicesgforgdrugginformationgwouldgincludegangappropriategdruggreferencegandgthegclini
calgpharmacist.
3. Whengdescribinggthegvariousgtypesgofgmedicationsgtogaggroupgofgnursinggstudents,g
agnursingginstructorgwouldgidentifygwhichgofgthegfollowinggasgagsourcegforgderivin
ggmedications?gSelectgallgthatgapply.
A) Plants
B) Syntheticgsources
C) Mold
D) Minerals
E) AnimalsgAn
s:gA,gB,gC,gD,gE
Feedback:
Medicationsgaregderivedgfromgnaturalgsources,gforgexample,gplants,gmolds,gminerals,gan
dganimals,gasgwellgasgcreatedgsyntheticallygingaglaboratory.
Pageg 1
,Introductory Clinical Pharmacology Test Bank for R
g g g g g g
oach's By Ford MN RN CNE, Susan M TEST BANK
g g g g g g g g g
With Rationale
g
4. Whichgofgthegfollowinggnamesgmaygbegassignedgtogagdruggduringgthegprocessg
ofgdevelopment?gSelectgallgthatgapply.
A) Chemicalgname
B) Officialgname
C) Pharmacologicgname
D) Tradegname
E) Nonproprietarygname
gAns:g A,gB,gD,gE
Feedback:
Throughoutgthegprocessgofgdevelopment,gdrugsgmayghavegseveralgnamesgassignedgtogth
emgincludinggagchemicalgname,gaggenericg(nonproprietary)gname,gangofficialgname,gandg
agtradegorgbrandgname.
5. Agdruggmaygbegclassifiedgbygwhichgofgthegfollowing?gSelectgallgthatgapply.
A) Thegchemicalgtypegofgthegdrug'sgactivegingredient
B) Thegwaygthegdruggisgusedgtogtreatgagspecificgcondition
C) Theggenericgnamegofgthegdrug
D) Thegtradegnamegofgthegdrug
E) Thegnonproprietarygnamegofgthegdru
ggAns:gA,gB
Feedback:
Agdruggmaygbegclassifiedgbygthegchemicalgtypegofgthegactivegingredientgorgbygthegwaygitg
isgusedgtogtreatgagparticulargcondition.gGeneric,gtrade,gandgnonproprietarygrefergtoghowga
gdruggisgnamed.
6. Aggroupgofgnursinggstudentsgaregreviewingginformationgaboutgthegprocessgofgdruggde
velopmentgingthegUnitedgStates.gThegstudentsgdemonstrategunderstandinggofgthisgpro
cessgwhengtheygidentifygthatgwhichgofgthegfollowinggcategoriesgaregassignedgbygthegF
oodgandgDruggAdministrationgtognewlygapprovedgdrugs?gSelectgallgthatgapply.
A) Metabolite
B) Noncontrolledgsubstance
C) Prescription
D) Nonprescription
E) Controlledgsubstance
gAns:gC,gD,gE
Feedback:
Oncegdrugsgaregapprovedgforguse,gthegFDAgassignsgthegdruggtogonegofgthegfollowinggcat
egories:gprescription,gnonprescription,gorgcontrolledgsubstance.gMetabolitegrefersgtogtheg
inactivegformgofgthegdrug.gNoncontrolledgsubstancegisgagtermgthatgisgnotgused.
Pageg 2
,Introductory Clinical Pharmacology Test Bank for R
g g g g g g
oach's By Ford MN RN CNE, Susan M TEST BANK
g g g g g g g g g
With Rationale
g
7. hichgofgthegfollowinggwouldgbegmostgimportantgforgthegnursegtogdogtogensuregthegsaf
egusegofgprescriptiongdrugsgingtheginstitutionalgsetting?gSelectgallgthatgapply.
A) Administeringgdrugs
B) Monitoringgclientsgforgdruggeffects
C) Prescribinggdrugs
D) Evaluatinggclientsgforgtoxicgeffects
E) Educatinggclients/caregiversgaboutgdrugs
gAns:gA,gB,gD,gE
Feedback:
Ingtheginstitutionalgsetting,gthegnurse'sgrolegtogensuregsafegusegofgprescriptiongdrugsgincl
udesgadministeringgdrugs,gmonitoringgdruggeffects,gevaluatinggforgtoxicgeffects,gandgedu
catinggclientsgandgcaregiversgaboutgdrugs.
8. Thegnursegisghelpinggagclientgreviewgagprescriptiongfromgtheghealthgcaregprovider.gWhe
ngexamininggthegprescription,gwhichgofgthegfollowinggwouldgthegnursegexpectgtogfindg
documented?gSelectgallgthatgapply.
A) Namegofgthegdrug
B) Dosagegofgthegdrug
C) Routegofgdruggadministration
D) Timesgofgdruggadministration
E) Licensedgprescriber'sgsignatur
egAns:gA,gB,gC,gD,gE
Feedback:
Thegprescriptiongmustgcontaingthegclient'sgname,gthegnamegofgthegdrug,gthegdosage,gtheg
methodgandgtimesgofgadministration,gandgthegsignaturegofgtheglicensedghealthgcaregprovi
dergprescribinggthegdrug.
9. Aftergteachinggaggroupgofgnursinggstudentsgaboutgnonprescriptiongdrugs,gthegnursinggin
structorgdeterminesgthatgthegteachinggwasgsuccessfulgwhengthegstudentsgidentifygwhichg
ofgthegfollowing?gSelectgallgthatgapply.
A) Theygrequiregaglicensedghealthgcaregprovider'sgsignature.
B) Theygaregreferredgtogasgover-the-countergdrugs.
C) Theygcangbegtakengwithoutgriskgtogthegclient.
D) Theyghavegcertainglabelinggrequirements.
E) Theygshouldgbegtakengonlygasgdirectedgongtheglabel
.gAns:gB,gD,gE
Feedback:
Nonprescriptiongdrugsgaregoftengreferredgtogasgover-the-
counterg(OTC)gdrugs.gTheygdognotgrequiregagprescriptiong(aglicensedghealthgcaregprovid
er'sgsignature)gbutgdognotgcomegwithoutgriskgtogthegclient.gThegfederalggovernmentghasgi
mposedglabelinggrequirementsgofgOTCgdrugsgandgtheygshouldgonlygbegtakengasgdirected
gongtheglabelgunlessgundergthegsupervisiongofgaghealthgcaregprovider.
Pageg 3
, Introductory Clinical Pharmacology Test Bank for R
g g g g g g
oach's By Ford MN RN CNE, Susan M TEST BANK
g g g g g g g g g
With Rationale
g
10. AgnursinggstudentgisgreviewingginformationgaboutgthegControlledgSubstancesgActgofg
1970.gThegstudentgwouldgexpectgtogfindgwhichgofgthegfollowinggasgbeinggregulatedgf
orgdrugsgclassifiedgasgcontrolledgsubstances?gSelectgallgthatgapply.
A) Manufacturing
B) Elimination
C) Distribution
D) Formulation
E) Dispensing
gAns:gA,gC,gE
Feedback:
ThegControlledgSubstancesgActgofg1970gregulatesgthegmanufacture,gdistribution,gandgdis
pensinggofgdrugsgclassifiedgasgcontrolledgsubstances.gEliminationgrefersgtogthegexcretion
gofgdrugsgfromgthegbody,gagpharmacokineticgactivity.gThegactgdoesgnotgaddressgformulati
ongofgthegdrug.
11. WhengreviewingginformationgaboutgthegOrphangDruggProgram,gwhichgofgthegfollowin
ggwouldgthegnursegexpectgtogfind?gSelectgallgthatgapply.
A) Thegprogramgencouragesgthegdevelopmentgandgmarketinggofgproductsgtogtreatgrar
egdiseases.
B) Thegprogramggrantsgprovisionalgapprovalgwithgagwrittengcommitmentgfromgth
egdruggcompanygtogformallygdemonstrategclientgbenefits.
C) Thegprogramgprovidesgforgincentives,gsuchgasgresearchggrants,gprotocolgassistance
,gandgspecialgtaxgcredits,gtogdevelopgproductsgtogtreatgraregdiseases.
D) Thegprogramggrantsg7gyearsgofgexclusivegmarketinggrightsgtogthegmanufacturergi
fgapproved.
E) Thegprogramgacceleratesgapprovalgofgdrugsgbasedgongpreliminarygevidencegbefor
egformalgdemonstrationgofgclientgbenefits.
Ans:g A,gC,gD
Feedback:
ThegOrphangDruggProgramgencouragesgthegdevelopmentgandgmarketinggofgproductsguse
dgtogtreatgraregdiseases.gThegprogramgprovidesgincentivesgtogencouragegmanufacturersgt
ogdevelopgorphangdrugs,gandgifgapproved,gthegmanufacturerghasg7gyearsgofgexclusivegm
arketinggrights.gAcceleratedgprogramsginvolvegprovisionalgapprovalgandgapprovalgbased
gongpreliminarygevidence.
Pageg 4
